TY - JOUR
TI - Embryonal rhabdomyosarcoma of the uterine cervix
AU - Koukourakis, G.V.
AU - Kouloulias, V.
AU - Zacharias, G.
AU - Maravelis, G.
AU - Papadimitriou, C.
AU - Platoni, K.
AU - Gouliamos, A.
JO - Clinical and Translational Oncology
PY - 2009
VL - 11
TODO - 6
SP - 399-402
PB - 
SN - 1699-048X, 1699-3055
TODO - 10.1007/s12094-009-0376-0
TODO - antineoplastic agent;  cisplatin;  etoposide;  ifosfamide, adjuvant chemotherapy;  adjuvant therapy;  adult;  brachytherapy;  case report;  computer assisted radiotherapy;  diagnostic error;  embryonal rhabdomyosarcoma;  female;  human;  hysterectomy;  lymphadenectomy;  magnetic and electromagnetic equipment;  methodology;  multimodality cancer therapy;  ovariectomy;  pathology;  photon;  polyp;  remission;  review;  uterine cervix tumor;  uterus bleeding, Antineoplastic Combined Chemotherapy Protocols;  Brachytherapy;  Chemotherapy, Adjuvant;  Cisplatin;  Combined Modality Therapy;  Diagnostic Errors;  Etoposide;  Female;  Humans;  Hysterectomy;  Ifosfamide;  Lymph Node Excision;  Ovariectomy;  Particle Accelerators;  Photons;  Polyps;  Radiotherapy, Adjuvant;  Radiotherapy, Conformal;  Remission Induction;  Rhabdomyosarcoma, Embryonal;  Uterine Cervical Neoplasms;  Uterine Hemorrhage;  Young Adult
TODO - Introduction Embryonal rhabdomyosarcoma (RMS) of the uterine cervix is a rare and extremely malignant entity. Generally, embryonal RMS originating in the uterine cervix is usually diagnosed in adolescence. Before the introduction of effective adjuvant chemotherapy, the prognosis of these lesions was poor. We have treated a young woman suffering from this disease using a combination of surgery, chemotherapy and radiation therapy (RT) with excellent results. The medical community should keep in mind that embryonal RMS of the uterine cervix, despite its malignancy and rarity, can be cured if adequate treatment is given. Case A case of a young woman aged 20, presenting with vaginal bleeding, is reported. The histological examination revealed embryonal RMS of uterine cervix. The patient was treated with a combination of surgery, chemotherapy and RT. A review in the literature, which is also presented, shows that the combined treatment of embryonal RMS using surgery and multidrug chemotherapy has signifi cantly improved survival. Conclusion Patients with favourable prognostic parameters, such as localised disease without deep myometrial invasion, single polyp and embryonal histologic subtype, can effectively be treated by surgery. Patients with unfavourable prognostic parameters seem to benefit from a multimodality approach including surgery, adjuvant chemotherapy and RT.
ER -